/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Mirati Therapeutics, Inc. ("Mirati" or the "Company") (NASDAQ: MRTX). Such.
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Mirati Therapeutics, Inc. ("Mirati" or the "Company") (NASDAQ: MRTX). Such.
NEW YORK, July 25, 2023 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Mirati Therapeutics, Inc. . Such investors are advised to contact Robert S. Willoughby.
SAN DIEGO and ZUG, Switzerland, July 21, 2023 /PRNewswire/ Mirati Therapeutics, Inc.® , a commercial stage biotechnology company, today announced the European Medicine Agency s Committee for.
Mirati Therapeutics (MRTX) Provides Update on Regulatory Review in EU of KRAZATI streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.